Horizon Europe is the European Union (EU) funding programme for the period 2021 – 2027, which targets the sectors of research and innovation. The programme’s budget is around € 95.5 billion, of which € 5.4 billion is from NextGenerationEU to stimulate recovery and strengthen the EU’s resilience in the future, and € 4.5 billion is additional aid.
While cancer research and innovation have generated novel treatment options, cancer patients across Europe need access to minimally-invasive, patient-centred diagnostic interventions which keep up with increasing demand in a complex and fragmented oncology healthcare landscape with increasing healthcare costs.
Pragmatic clinical trials focus on choosing between care options. Pragmatic trials evaluate effectiveness, the effect of diagnostics in routine (real-world) clinical practice.
Proposals should address all of the following:
100%
EU Contribution per project: between €6,00 and €8,00 million
These pragmatic clinical trials should include stakeholders such as:
Research and Innovation Foundation
29a Andrea Michalakopoulou, 1075 Nicosia
P.B. 23422, 1683 Nicosia
Telephone: +357 22205000
Fax: +357 22205001
Email: support@research.org.cy
Contact Person:
George Christou
Scientific Officer
gchristou@research.org.cy
(Publish Date: 10/02/2023-for internal use only)